A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
Sponsored by Invenio Imaging Inc.
About this study
The ON-SITE study represents a prospective, observational study focused on the training/tuning and pivotal validation of deep learning algorithms that detect cell/tissue morphology suspicious for cancer in biopsies of peripheral lung nodules/masses and mediastinal/hilar lymph nodes imaged with the NIO Laser Imaging System in the procedure room without requiring traditional sample processing. The study includes four arms based on biopsy location and biopsy modality/tool: 1. Transbronchial forceps biopsy of peripheral lung nodules/masses (peripheral-TBBx) 2. Transbronchial needle aspiration biopsy of peripheral lung nodules/masses (peripheral TBNA) 3. Transbronchial needle aspiration biopsy of mediastinal/hilar lymph nodes (EBUS-TBNA) 4. Transbronchial cryo biopsy of peripheral lung nodules/masses (peripheral-CBx)
Where this study is enrolling (5)
- I'm interested
UC San Diego
San Diego, California
- I'm interested
Mayo Clinic Jacksonville
Jacksonville, Florida
- I'm interested
Corewell Health
Grand Rapids, Michigan
- I'm interested
Montefiore Medical Center
The Bronx, New York
- I'm interested
UNC Medical Center
Chapel Hill, North Carolina
Who can participate
Inclusion criteria
- ✓1. The patient or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.
- ✓2. The patient is 22 years of age or older.
- ✓3. The patient is scheduled for routinely indicated staging of the mediastinum (EBUS-TBNA) and planned peripheral lung biopsy procedure (peripheral TBBx/TBNA) with an intermediate to high pretest probability of lung cancer based on clinician suspicion.
- ✓4. The patient can tolerate the clinical procedure as indicated.
Exclusion criteria
- ✕1. Patient is a prisoner.
- ✕2. The participant, in the judgment of the Investigator, may be inappropriate for the intended study procedures
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.